| 000 | 01554 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518013429.0 | ||
| 264 | 0 | _c20190107 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a2041-1723 | ||
| 024 | 7 |
_a10.1038/s41467-018-07232-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRosario, S R | |
| 245 | 0 | 0 |
_aPan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas. _h[electronic resource] |
| 260 |
_bNature communications _c12 2018 |
||
| 300 |
_a5330 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 | _aCellular Reprogramming |
| 650 | 0 | 4 |
_aCitric Acid Cycle _xdrug effects |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGenome, Human |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xdrug effects |
| 650 | 0 | 4 |
_aMetformin _xpharmacology |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aPolyamines _xmetabolism |
| 650 | 0 | 4 |
_aSulfasalazine _xpharmacology |
| 650 | 0 | 4 |
_aTranscriptome _xdrug effects |
| 700 | 1 | _aLong, M D | |
| 700 | 1 | _aAffronti, H C | |
| 700 | 1 | _aRowsam, A M | |
| 700 | 1 | _aEng, K H | |
| 700 | 1 | _aSmiraglia, D J | |
| 773 | 0 |
_tNature communications _gvol. 9 _gno. 1 _gp. 5330 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41467-018-07232-8 _zAvailable from publisher's website |
| 999 |
_c29165197 _d29165197 |
||